LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW)

CUSIP: 55068A118

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
699,823
Share change
+699,823
Total reported value
$1,744,000
Price per share
$2.49
Number of holders
5
Value change
+$1,744,000
Number of buys
5

Quarterly Holders Quick Answers

What is CUSIP 55068A118?
CUSIP 55068A118 identifies LUXAW - LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW) as of Q4 2020

As of 31 Dec 2020, LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 699,823 shares. The largest 5 holders included Castle Creek Arbitrage, LLC, RP Investment Advisors LP, Weiss Asset Management LP, Sculptor Capital LP, and CAAS CAPITAL MANAGEMENT LP. This page lists 5 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.